Silver lining: reduced relapse with chronic GVHD after transplant for MDS | Aplastic Anemia & MDS International Foundation

Silver lining: reduced relapse with chronic GVHD after transplant for MDS

Journal Title: 
Clinical Cancer Research: an official Journal of the American Association of Cancer Research
Primary Author: 
Eckel AM
Author(s): 
Eckel AM, Deeg HJ
Original Publication Date: 
Friday, October 16, 2020

Chronic graft-versus-host disease (GVHD) following hematopoietic cell transplantation is associated with reduced relapse incidence in patients with leukemias. This impact has been investigated in myelodysplastic syndrome, showing a beneficial impact of limited chronic GVHD on transplant outcomes in a cohort of more than 3,000 patients.